Delivery Order SPE2DE24D0013-SPE2D625F2WXY

Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, received a $7,480 firm fixed-price delivery order from the Medical Supply Chain (Defense) on September 9, 2025, with an ultimate completion date of September 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the procurement of molecular diagnostic solutions, specifically test kits and related supplies for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award includes no set-aside designation and represents a continuation of Cepheid's established relationship with federal defense healthcare agencies. The delivery order is likely associated with one of Cepheid's larger Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which provide ongoing access to the company's GeneXpert diagnostic systems and molecular reagents.

Cepheid's extensive track record with federal agencies, particularly the Veterans Health Administration and Defense Logistics Agency, demonstrates its competitive positioning in the federal molecular diagnostics market. The company's core offerings include diagnostic equipment, test reagents, and maintenance services designed to support infectious disease detection across multiple federal healthcare systems. This relatively modest delivery order reflects routine procurement activities under existing vehicle contracts that authorize continuous ordering of proven diagnostic technologies to support federal medical supply chain requirements.